Social desirability bias in family planning studies: a neglected problem

Contraception

Volumn 80, Issue 2, 2009, Pages 108-112

  Stuart, Gretchen S ^a   Grimes, David A ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ORAL CONTRACEPTIVE AGENT; PROSTATE SPECIFIC ANTIGEN;

ANONYMOUS TESTING; ARTICLE; BARRIER CONTRACEPTION; BREAST CANCER; CANCER RISK; CHLAMYDIASIS; COITUS; COMPUTER INTERFACE; CONDOM; CONFIDENTIALITY; DRUG EFFICACY; DRUG MONITORING; ELECTRONIC MEDICAL RECORD; FAMILY PLANNING; GENITAL TRACT INFECTION; HORMONAL CONTRACEPTION; HUMAN; INDUCED ABORTION; INTERVIEW; INTERVIEW BIAS; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PELVIC INFLAMMATORY DISEASE; QUESTIONNAIRE; SELF REPORT; SEXUAL INTERCOURSE; SOCIAL DESIRABILITY; UNSAFE SEX; VAGINA SECRETION;

EID: 67651052239     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.02.009     Document Type: Note

References (44)

1. Guest G., Bunce A., Johnson L., Akumatey B., and Adeokun L. Fear, hope and social desirability bias among women at high risk for HIV in West Africa. J Fam Plann Reprod Health Care 31 (2005) 285-287
2. Turner A.N., De Kock A.E., Meehan-Ritter A., et al. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol (2008 Nov 13) [Epub ahead of print]
3. Villarroel M.A., Turner C.F., Rogers S.M., et al. T-ACASI reduces bias in STD measurements: the National STD and Behavior Measurement Experiment. Sex Transm Dis 35 (2008) 499-506
4. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr 167 (1997) 17-36
5. Hebert J.R., Hurley T.G., Peterson K.E., et al. Social desirability trait influences on self-reported dietary measures among diverse participants in a multicenter multiple risk factor trial. J Nutr 138 (2008) 226S-234S
6. Hebert J.R., Clemow L., Pbert L., Ockene I.S., and Ockene J.K. Social desirability bias in dietary self-report may compromise the validity of dietary intake measures. Int J Epidemiol 24 (1995) 389-398
7. Skarbinski J., Winston C.A., Massaga J.J., Kachur S.P., and Rowe A.K. Assessing the validity of health facility-based data on insecticide-treated bednet possession and use: comparison of data collected via health facility and household surveys - Lindi region and Rufiji district, Tanzania, 2005. Trop Med Int Health 13 (2008) 396-405
8. Gregson S., Zhuwau T., Ndlovu J., and Nyamukapa C.A. Methods to reduce social desirability bias in sex surveys in low-development settings: experience in Zimbabwe. Sex Transm Dis 29 (2002) 568-575
9. Fu H, Darroch JE, Henshaw SK, Kolb E. Measuring the extent of abortion underreporting in the 1995 National Survey of Family Growth. Fam Plann Perspect 1998;30:128-33, 138.
10. Kost K., Singh S., Vaughan B., Trussell J., and Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 77 (2008) 10-21
11. Jagannathan R. Relying on surveys to understand abortion behavior: some cautionary evidence. Am J Public Health 91 (2001) 1825-1831
12. Beral V., Bull D., Doll R., Peto R., and Reeves G. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 363 (2004) 1007-1016
13. Stone A.A., Shiffman S., Schwartz J.E., Broderick J.E., and Hufford M.R. Patient non-compliance with paper diaries. BMJ 324 (2002) 1193-1194
14. Cleland J., Boerma J.T., Carael M., and Weir S.S. Monitoring sexual behaviour in general populations: a synthesis of lessons of the past decade. Sex Transm Infect 80 Suppl 2 (2004) ii1-ii7
15. Mauck C.K., and Doncel G.F. Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception 75 (2007) 407-419
16. Macaluso M., Lawson L., Akers R., et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception 59 (1999) 195-201
17. Walsh T.L., Frezieres R.G., Nelson A.L., Wraxall B.G., and Clark V.A. Evaluation of prostate-specific antigen as a quantifiable indicator of condom failure in clinical trials. Contraception 60 (1999) 289-298
18. Walsh T.L., Frezieres R.G., Peacock K., et al. Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted disease. Contraception 67 (2003) 139-150
19. Gallo M.F., Behets F.M., Steiner M.J., et al. Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis 33 (2006) 476-479
20. Gallo M.F., Behets F.M., Steiner M.J., et al. Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya-PSA analysis. Int J STD AIDS 18 (2007) 33-38
21. Zenilman J.M., Weisman C.S., Rompalo A.M., et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis 22 (1995) 15-21
22. Gallo M.F., Steiner M.J., Warner L., et al. Self-reported condom use is associated with reduced risk of chlamydia, gonorrhea, and trichomoniasis. Sex Transm Dis 34 (2007) 829-833
23. Thomsen S.C., Gallo M.F., Ombidi W., et al. Randomised controlled trial on whether advance knowledge of prostate-specific antigen testing improves participant reporting of unprotected sex. Sex Transm Infect 83 (2007) 419-420
24. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21 (1999) 1074-1090
25. Potter L., Oakley D., de Leon-Wong E., and Canamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect 28 (1996) 154-158
26. Bachmann L.H., Stephens J., Richey C.M., and Hook III E.W. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis 26 (1999) 272-278
27. Dunbar-Jacob J., Sereika S.M., Foley S.M., Bass D.C., and Ness R.B. Adherence to oral therapies in pelvic inflammatory disease. J Womens Health (Larchmt) 13 (2004) 285-291
28. Oakley D, Potter L, de Leon-Wong E, Visness C. Oral contraceptive use and protective behavior after missed pills. Fam Plann Perspect 1997;29:277-9, 287.
29. Ickovics J.R., Wilson T.E., Royce R.A., et al. Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr 30 (2002) 311-315
30. Wu J.R., Moser D.K., Chung M.L., and Lennie T.A. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 14 (2008) 203-210
31. Parker C.S., Chen Z., Price M., et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med 22 (2007) 1254-1259
32. Choo P.W., Rand C.S., Inui T.S., et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37 (1999) 846-857
33. Miller L.G., and Hays R.D. Measuring adherence to antiretroviral medications in clinical trials. HIV Clin Trials 1 (2000) 36-46
34. Schwed A., Fallab C.L., Burnier M., et al. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. J Clin Pharmacol 39 (1999) 402-409
35. Guttmacher Institute. Facts on induced abortion in the United States; in brief reports. Alan Guttmacher Institute (July/2008). Available from: URL:. http://www.guttmacher.org/pubs/fb_induced_abortion.html
36. Lindefors-Harris B.M., Eklund G., Adami H.O., and Meirik O. Response bias in a case-control study: analysis utilizing comparative data concerning legal abortions from two independent Swedish studies. Am J Epidemiol 134 (1991) 1003-1008
37. Allen C.F., Lees S.S., Desmond N.A., et al. Validity of coital diaries in a feasibility study for the Microbicides Development Programme trial among women at high risk of HIV/AIDS in Mwanza, Tanzania. Sex Transm Infect 83 (2007) 490-496
38. NIMH Multisite HIV/STD Prevention Trial for African American Couples Group. Designing an audio computer-assisted self-interview (ACASI) system in a multisite trial: a brief report. J Acquir Immune Defic Syndr 49 Suppl 1 (2008) S52-S58
39. Minnis A.M., Muchini A., Shiboski S., et al. Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception 75 (2007) 59-65
40. Morrison C.S., Richardson B.A., Mmiro F., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21 (2007) 85-95
41. Waruru A.K., Nduati R., and Tylleskar T. Audio computer-assisted self-interviewing (ACASI) may avert socially desirable responses about infant feeding in the context of HIV. BMC Med Inform Decis Mak 5 (2005) 24
42. Villarroel M.A., Turner C.F., Eggleston E., et al. Same-gender sex in the United States: impact of T-ACASI on prevalence estimates (telephone audio computer-assisted self-interviewing). Public Opin Q 70 (2006) 166
43. Steiner M., Dominik R., Trussell J., and Hertz-Picciott I. Measuring contraceptive effectiveness: a conceptual framework. Obstet Gynecol 88 (1996) 24S-30S
44. Steiner M.J., Kwok C., Dominik R., et al. Pregnancy risk among oral contraceptive pill, injectable contraceptive, and condom users in Uganda, Zimbabwe, and Thailand. Obstet Gynecol 110 (2007) 1003-1009